AURKA and gastric cancer: The 5-year OS rate was 53.9% in GC patients with low AURKA expression compared to 31.1% in patients with high expression (p = 0.01), which demonstrated that the high expression of AURKA in GC tissues correlated with a shorter survival time (Figure 1C).